Sign in

CIK 0001653087 · Accelerated filer<br>Smaller reporting company

Alector, Inc.

Sign in to watch
Ticker
ALEC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
822933343
Phone
415-231-5660
Business address
131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO, CA, 94080
Former names
Alector LLC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$296,087
in 3 filings

Net −$296,087. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Rosenthal Arnon −$193K Chief Executive Officer sold 3% of stake
  2. Berkley Neil Lindsay −$78K CFO & Chief Business Officer sold 8% of stake
  3. Wong-Sarad Grace −$25K Principal Accounting Officer sold 8% of stake

Reading 76 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-06-16 Hammond Paula Director Grant or award · Stock Option (right to buy) +18,918 18,918
2022-06-16 Gerngross Tillman U. Director Grant or award +9,459 2,618,069
2022-06-16 Gerngross Tillman U. Director Grant or award · Stock Option (right to buy) +18,918 18,918
2022-06-16 GAROFALO ELIZABETH A. Director Grant or award +9,459 9,459
2022-06-16 GAROFALO ELIZABETH A. Director Grant or award · Stock Option (right to buy) +18,918 18,918
2022-06-02 King Robert Chief Development Officer Sale −177 $8.71 $2K 529,471
2022-05-27 Romano Gary Chief Medical Officer Grant or award +92,250 92,250
2022-05-27 Romano Gary Chief Medical Officer Grant or award · Employee Stock Option (right to buy) +369,000 369,000
2022-03-01 King Robert Chief Development Officer Sale −287 $15.57 $4K 528,404
2022-03-01 GRASSO MARC Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +450,000 450,000
2022-01-03 Kenkare-Mitra Sara President and Head of R&D Grant or award +59,000 59,000
2022-01-03 Kenkare-Mitra Sara President and Head of R&D Grant or award +59,000 118,000
2022-01-03 Kenkare-Mitra Sara President and Head of R&D Grant or award · Employee Stock Option (right to buy) +300,000 300,000
2021-12-21 Polaris Venture Management Co. VI, L.L.C. 10% owner Other disposition −500,000 12,353,817
2021-12-21 Polaris Venture Management Co. VI, L.L.C. 10% owner Other acquisition +98,533 98,533
2021-12-21 Polaris Venture Management Co. VI, L.L.C. 10% owner Other disposition −98,533 0
2021-12-21 MCGUIRE TERRANCE Director Other disposition −500,000 12,353,817
2021-12-21 MCGUIRE TERRANCE Director Other acquisition +6,429 6,429
2021-12-21 MCGUIRE TERRANCE Director Other acquisition +98,533 98,533
2021-12-21 MCGUIRE TERRANCE Director Other disposition −98,533 0

Page 13 of 23 · 454 trades